Fundz

Fundz Deep Dive

Everything you need to win Dayna Schwartz — in one platform.

Who to reach, what to say, and why now on Dayna Schwartz — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Dayna Schwartz — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Clarametyx Biosciences Appoints Steve St. Onge As Senior Vice President of Corporate Development and Dayna Schwartz As Director of Clinical Development and Portfolio Strategy

PRIVATEApr 22, 2024•about 2 years ago

Position

Director

Company

Clarametyx Biosciences

Dayna Schwartz
ColumbusBiotechnologyHealth Care

Description

Clarametyx Biosciences has appointed Steve St. Onge as Senior Vice President of Corporate Development and Dayna Schwartz as Director of Clinical Development and Portfolio Strategy. This strategic move aims to further build the company’s pipeline momentum following the completion of the Series A and the start of a clinical trial in cystic fibrosis.

Company Information

Company

Clarametyx Biosciences

Location

Columbus, Ohio, United States

About

Clarametyx Biosciences is combating the formidable challenge of chronic respiratory diseases through an innovative technology platform targeting the biofilm—a protective layer around bacteria that drives inflammation and disease exacerbation. The Columbus, Ohio-based company is building a pipeline of immune-enabling therapies and vaccines, including CMTX-101, which is in a Phase 2 study for cystic fibrosis-related, biofilm-driven infections, and CMTX-301, which is in preclinical development.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Clarametyx Biosciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.